Skip to main content

Post-IPO Equity Medical Companies

Explore 243 medical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
243
Total Funding
$1.6B
Avg Funding
$63.2M
Cities
22

Export 243 Post-IPO Equity Medical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Ashburn, United States
$104.5M
raised

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$5.9M
raised

Vicarious Surgical is a robotics company that develops robotic systems that allow surgeons to perform minimally invasive surgery.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$80.0M
raised

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$58.9M
raised

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carmel, United States
$2.8M
raised

NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Penarth, United Kingdom
$9.4M
raised

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lexington, United States
$60.0M
raised

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$115.0M
raised

PepGen is empowering nucleic acid therapeutics to go the distance.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$754K
raised

Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States
$401.0M
raised

Flora Growth is a cannabis company that leverages natural cultivation practices.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$1.1M
raised

Scryb is a platform that powers businesses and technologies with applied intelligence, real-time analytics & actionable insights.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Florida, United States
$5.3M
raised

Nutriband is an innovative and progressive health and lifestyle company.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Richmond, Canada
$1.5M
raised

Herbal Dispatch Cannabis Club is online mail order dispensary, provide access to the small-batch craft cannabis.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Westbrook, United States
$4.4M
raised

One of the most innovative consumer healthcare and beauty companies in North America.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Melville, United States
$400.0M
raised

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pointe-claire, Canada
$1.7M
raised

Devonian is a late stage botanical pharmaceutical corporation

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wexford, United States
$4.0M
raised

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$2.2M
raised

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Denver, United States
$4.4M
raised

SeaStar Medical is a commercial-stage medical device company that develops immunomodulating technologies.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$100.0M
raised

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$8.5M
raised

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$19.0M
raised

INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Omaha, United States
$11.0M
raised

Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 243 companies

Ready to Connect with Post-IPO Equity Medical Startups?

Get verified founder emails, funding details, and company data for 243 post-ipo equity medical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

243 Medical Post-IPO Equity Startups (November 2026) — Page 6 | VCBacked